PRESS RELEASE published on 12/03/2025 at 17:45, 9 months 9 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights & shares as of Nov 30, 2025, in compliance with French regulations. Company pioneers AI for cancer diagnosis & treatment Voting Rights Shares French Regulations Median Technologies Cancer Diagnosis
BRIEF published on 10/21/2025 at 17:50, 10 months 22 days ago Median Technologies reçoit un financement de 19 millions d'euros de la BEI Financement Banque Européenne D’Investissement Median Technologies Diagnostic Du Cancer Eyonis® LCS
BRIEF published on 10/21/2025 at 17:50, 10 months 22 days ago Median Technologies receives €19 million in financing from the EIB Funding European Investment Bank Median Technologies Cancer Diagnosis Eyonis® LCS
PRESS RELEASE published on 10/21/2025 at 17:45, 10 months 22 days ago Informations privilégiées / Autres communiqués Median Technologies reçoit 19 millions d’euros de la BEI pour eyonis® LCS et étend son horizon de trésorerie jusqu'en 2026 Financement Trésorerie Median Technologies BEI Eyonis® LCS
BRIEF published on 10/13/2025 at 17:50, 10 months 30 days ago Median Technologies: Documents available for the AGM of October 31, 2025 Shareholders Paris General Assembly Preparatory Documents Median Technologies
BRIEF published on 10/13/2025 at 17:50, 10 months 30 days ago Median Technologies: Mise à disposition des documents pour l'AG du 31 octobre 2025 Actionnaires Paris Assemblée Générale Documents Préparatoires Median Technologies
PRESS RELEASE published on 10/13/2025 at 17:45, 10 months 30 days ago Modalités de mise à disposition des documents préparatoires à l'AG Median Technologies annonce la mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 31 octobre 2025 Actionnaires Convocation Documents Préparatoires Assemblée Générale Mixte Median Technologies
BRIEF published on 08/07/2025 at 17:50, 1 year 1 month ago MEDIAN TECHNOLOGIES : Mise à jour des droits de vote et du capital social Actions Propres Capital Social Droit De Vote Réglementation Française TECHNOLOGIES MÉDIANE
BRIEF published on 08/07/2025 at 17:50, 1 year 1 month ago MEDIAN TECHNOLOGIES: Voting Rights and Share Capital Update Share Capital Voting Rights French Regulations Treasury Shares Median Technologies
PRESS RELEASE published on 08/07/2025 at 17:45, 1 year 1 month ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights and shares as of July 31, 2025, per French regulations. The company pioneers AI-driven medical software for cancer diagnosis and treatment Voting Rights Shares Median Technologies Cancer Diagnosis AI-driven Software
Published on 09/12/2026 at 02:35, 1 day 5 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 9 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 10 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 15 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 14 hours 9 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 9 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 9 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 12 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 1 hour ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 1 hour ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 12 hours ago Availability of the 2026 Interim Financial Report